Patient Access

Articles for Patient Access

During a general session at America’s Health Insurance Plans’ Institute & Expo, held June 7-9 in Austin, Texas, Eric Topol, MD, explained the buzz behind precision medicine and why it is needed to combat the harms of imprecision in medicine.
A tailored approach to value assessment will help drive innovation and impact patient outcomes and access to care, said Ilene Hollin, PhD, MPH, of the National Pharmaceutical Council.
Panelists Joseph Alvarnas, MD; John Fox, MD; and Robert Carlson, MD, provide insight on the implications of manufacturer-physician communication and how this impacts patient access.
Leonard Lichtenfeld, MD, provides insight on the ethical and patient access considerations with off-label communications.
Susan A. Cantrell, RPh, CAE, CEO of the Academy of Managed Care Pharmacy (AMCP), discusses the biggest concerns and opportunities facing members of AMCP during this time of legislative and regulatory uncertainty and rising costs in healthcare.
Despite the wide variety of rare diseases out there, children and families living with rare disease have one thing in common: they experience diagnostic delays. A new study in Orphanet Journal of Rare Diseases described experiences of seeking and receiving a diagnosis of a rare disease and access to healthcare.
Have retail clinics changed the structure of our health system? Have they changed the way players in the system compete or interact with each other?
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST